- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Ablynx NV+ Add to Watchlist
ABLYF:US11.0800 USD 0.2100 1.86%
As of 20:10:08 ET on 02/27/2015.
Company Profile for Ablynx NV (ABLYF)
Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.
Key Executives for Ablynx NV (ABLYF)
|Edwin MosesChief Executive Officer||Wim OttevaereChief Financial Officer|
|Johan HeylenChief Commercial Officer||Josefin-Beate Holz "Josi"Chief Medical Officer|
|Marieke VermeerschAssociate Dir:Investor Relations|